TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biokjemi Norge AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
29,758
|
23,525
|
18,945 |
| Financial expenses |
235
|
290
|
214 |
| Earnings before taxes |
1,964
|
355
|
-1,763 |
| Total assets |
12,470
|
13,138
|
12,665 |
| Current assets |
9,617
|
10,249
|
9,608 |
| Current liabilities |
5,446
|
7,867
|
7,749 |
| Equity capital |
7,024
|
5,271
|
4,916 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.3%
|
40.1%
|
38.8% |
| Turnover per employee |
4,960
|
3,921
|
3,158 |
| Profit as a percentage of turnover |
6.6%
|
1.5%
|
-9.3% |
| Return on assets (ROA) |
17.6%
|
4.9%
|
-12.2% |
| Current ratio |
176.6%
|
130.3%
|
124.0% |
| Return on equity (ROE) |
28.0%
|
6.7%
|
-35.9% |
| Change turnover |
6,233
|
4,580
|
-5,996 |
| Change turnover % |
26%
|
24%
|
-24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.